PL1699434T3 - Sposób wytwarzania leku - Google Patents
Sposób wytwarzania lekuInfo
- Publication number
- PL1699434T3 PL1699434T3 PL04782768T PL04782768T PL1699434T3 PL 1699434 T3 PL1699434 T3 PL 1699434T3 PL 04782768 T PL04782768 T PL 04782768T PL 04782768 T PL04782768 T PL 04782768T PL 1699434 T3 PL1699434 T3 PL 1699434T3
- Authority
- PL
- Poland
- Prior art keywords
- agglomerate
- active ingredient
- primary particles
- preparing
- carrier
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 3
- 239000002245 particle Substances 0.000 abstract 3
- 239000011164 primary particle Substances 0.000 abstract 3
- 239000000463 material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49958203P | 2003-09-02 | 2003-09-02 | |
| PCT/US2004/028345 WO2005020963A1 (en) | 2003-09-02 | 2004-09-01 | Process for preparing a medicament |
| EP04782768A EP1699434B1 (en) | 2003-09-02 | 2004-09-01 | Process for preparing a medicament |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1699434T3 true PL1699434T3 (pl) | 2011-09-30 |
Family
ID=34272843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04782768T PL1699434T3 (pl) | 2003-09-02 | 2004-09-01 | Sposób wytwarzania leku |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US9345664B2 (pl) |
| EP (1) | EP1699434B1 (pl) |
| AT (1) | ATE498394T1 (pl) |
| CA (1) | CA2575957C (pl) |
| CY (1) | CY1113221T1 (pl) |
| DE (1) | DE602004031459D1 (pl) |
| DK (1) | DK1699434T3 (pl) |
| ES (1) | ES2362038T3 (pl) |
| PL (1) | PL1699434T3 (pl) |
| PT (1) | PT1699434E (pl) |
| SI (1) | SI1699434T1 (pl) |
| WO (1) | WO2005020963A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0219511D0 (en) * | 2002-08-21 | 2002-10-02 | Norton Healthcare Ltd | Method of preparing dry powder inhalation compositions |
| MXPA05001903A (es) * | 2002-08-21 | 2005-04-28 | Norton Healthcare Ltd | Composicion para inhalacion. |
| GB0327723D0 (en) | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
| EP1684767A1 (en) * | 2003-11-03 | 2006-08-02 | Norton Healthcare Limited | Soft steroid compositions for use in dry powder inhalers |
| WO2006087316A1 (en) * | 2005-02-16 | 2006-08-24 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions comprising anticholinergics and etiprednol |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3957965A (en) | 1967-08-08 | 1976-05-18 | Fisons Limited | Sodium chromoglycate inhalation medicament |
| GB1242211A (en) | 1967-08-08 | 1971-08-11 | Fisons Pharmaceuticals Ltd | Pharmaceutical composition |
| GB1569611A (en) | 1976-01-23 | 1980-06-18 | Fisons Ltd | Pelletised or granular medicament formulation |
| US4161516A (en) | 1975-07-25 | 1979-07-17 | Fisons Limited | Composition for treating airway disease |
| GB9027234D0 (en) | 1990-12-15 | 1991-02-06 | Harris Pharma Ltd | An inhalation device |
| IS1796B (is) | 1993-06-24 | 2001-12-31 | Ab Astra | Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband |
| TW402506B (en) * | 1993-06-24 | 2000-08-21 | Astra Ab | Therapeutic preparation for inhalation |
| IS1736B (is) | 1993-10-01 | 1999-12-30 | Astra Ab | Aðferð og tæki sem stuðla að aukinni samloðun agna |
| SE9400335D0 (sv) | 1994-02-02 | 1994-02-02 | Astra Ab | Powder mixing |
| AR002009A1 (es) * | 1994-12-22 | 1998-01-07 | Astra Ab | Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco. |
| EP0896525B1 (en) * | 1996-04-29 | 2003-08-27 | Dura Pharmaceuticals, Inc. | Methods of dry powder inhalation |
| SE9700135D0 (sv) | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
| DE10043509A1 (de) * | 2000-09-01 | 2002-03-14 | Asta Medica Ag | Feste Peptidzubereitungen für die Inhalation und deren Herstellung |
| UA75375C2 (en) | 2000-10-12 | 2006-04-17 | Boehringer Ingelheim Pharma | Method for producing powdery preparations for inhaling |
| DE10141376A1 (de) | 2001-08-23 | 2003-03-13 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung von Inhalationspulvern |
| AU2002333644A1 (en) | 2001-09-17 | 2003-04-01 | Glaxo Group Limited | Dry powder medicament formulations |
| US20050158248A1 (en) | 2002-08-21 | 2005-07-21 | Xian-Ming Zeng | Method of preparing dry powder inhalation compositions |
| MXPA05001903A (es) | 2002-08-21 | 2005-04-28 | Norton Healthcare Ltd | Composicion para inhalacion. |
| GB0219512D0 (en) | 2002-08-21 | 2002-10-02 | Norton Healthcare Ltd | Inhalation compositions with high drug ratios |
-
2004
- 2004-09-01 EP EP04782768A patent/EP1699434B1/en not_active Revoked
- 2004-09-01 AT AT04782768T patent/ATE498394T1/de active
- 2004-09-01 DK DK04782768.8T patent/DK1699434T3/da active
- 2004-09-01 WO PCT/US2004/028345 patent/WO2005020963A1/en not_active Ceased
- 2004-09-01 SI SI200431668T patent/SI1699434T1/sl unknown
- 2004-09-01 US US10/594,473 patent/US9345664B2/en active Active
- 2004-09-01 CA CA2575957A patent/CA2575957C/en not_active Expired - Fee Related
- 2004-09-01 PL PL04782768T patent/PL1699434T3/pl unknown
- 2004-09-01 ES ES04782768T patent/ES2362038T3/es not_active Expired - Lifetime
- 2004-09-01 PT PT04782768T patent/PT1699434E/pt unknown
- 2004-09-01 DE DE602004031459T patent/DE602004031459D1/de not_active Expired - Lifetime
-
2011
- 2011-05-06 CY CY20111100440T patent/CY1113221T1/el unknown
-
2016
- 2016-04-25 US US15/137,671 patent/US9616024B2/en not_active Expired - Fee Related
-
2017
- 2017-03-09 US US15/453,940 patent/US9987229B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1699434B1 (en) | 2011-02-16 |
| CA2575957C (en) | 2010-11-30 |
| ATE498394T1 (de) | 2011-03-15 |
| PT1699434E (pt) | 2011-05-03 |
| EP1699434A1 (en) | 2006-09-13 |
| CA2575957A1 (en) | 2005-03-10 |
| US20170172925A1 (en) | 2017-06-22 |
| SI1699434T1 (sl) | 2011-06-30 |
| US9616024B2 (en) | 2017-04-11 |
| CY1113221T1 (el) | 2016-04-13 |
| ES2362038T3 (es) | 2011-06-27 |
| DE602004031459D1 (de) | 2011-03-31 |
| DK1699434T3 (da) | 2011-05-30 |
| US20160235678A1 (en) | 2016-08-18 |
| US20080131518A1 (en) | 2008-06-05 |
| US9987229B2 (en) | 2018-06-05 |
| WO2005020963A1 (en) | 2005-03-10 |
| US9345664B2 (en) | 2016-05-24 |
| EP1699434A4 (en) | 2009-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200720307A (en) | Catalyst compositions comprising support materials having an improved particle-size distribution | |
| EP2357045A3 (en) | Method of manufacturing an electrode | |
| MXPA02008117A (es) | Particulas de ceramica de liberacion controlada composiciones de estas, procesos de su preparacion y metodos de uso. | |
| CA2534056A1 (en) | Calcium carbonate granulation | |
| MXPA03001181A (es) | Productos de perlita expandida con distribucion controlada de tamano de particula. | |
| CA2430318A1 (en) | Powder formulation and method for producing the same | |
| AU2002231360A1 (en) | Carbon block water filter | |
| ATE220563T1 (de) | Nichtklumpende superabsorbierende polymere | |
| CY1113221T1 (el) | Διεργασια για την παρασκευη ενος φαρμακου | |
| PL354257A1 (pl) | Sposób otrzymywania powlekanych granul o ukrytym sSposób otrzymywania powlekanych granul o ukrytym smaku, niezwłocznie uwalniających aktywny czynnikmaku, niezwłocznie uwalniających aktywny czynnik | |
| PT1418890E (pt) | Formulações de micropartículas à base de propulsor | |
| PL343342A1 (en) | Particulate active agent support for pulmonary application | |
| CA2455261A1 (en) | Sprinkling method for preparing powder formulations | |
| AU2001291627A1 (en) | Sustained release particle dispersion | |
| PL372615A1 (pl) | Kompozycje farmaceutyczne zawierające modafinil | |
| ATE370980T1 (de) | Sphärische pulverkomponenten und diese enthaltende feste kosmetische zusammensetzung | |
| WO2003090715A3 (en) | Particulate materials | |
| AU2662200A (en) | Method for producing hard metal mixtures | |
| AU2002314972A1 (en) | Compressible guaifenesin compositions and method for producing them | |
| MXPA04003892A (es) | Proceso para produccion de granulos de detergente. | |
| ES2171110A1 (es) | Composicion farmaceutica a base de ibuprofeno y procedimiento para su preparacion. | |
| CA2273849A1 (en) | Process for the production of a detergent composition | |
| WO2004033083A3 (en) | A method for improving particle compositions | |
| CN103720669A (zh) | 一种可压性维生素c颗粒的制备方法 | |
| KR970703711A (ko) | 황산콜리스틴을 함유하는 안정화된 조성물(stabilized composition comprising colistin sulfate) |